The Evaluation of Immunogenicity and Safety of NBP608 in Healthy Children 12 Months to 12 Years of Age

Condition:   Varicella Interventions:   Biological: NBP608;   Biological: Varivax Sponsor:   SK Chemicals Co.,Ltd. Completed - verified April 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials